Rare sugar d-psicose improves insulin sensitivity and glucose tolerance in type 2 diabetes Otsuka Long-Evans Tokushima Fatty (OLETF) rats

Biochemical and Biophysical Research Communications

Volumn 405, Issue 1, 2011, Pages 7-12

  Hossain, Mohammad A ^a   Kitagaki, Shigeru ^b   Nakano, Daisuke ^a   Nishiyama, Akira ^a   Funamoto, Yasunobu ^c   Matsunaga, Toru ^c   Tsukamoto, Ikuko ^a   Yamaguchi, Fuminori ^a   Kamitori, Kazuyo ^a   Dong, Youyi ^a   Hirata, Yuko ^a   Murao, Koji ^a   Toyoda, Yukiyasu ^d   Tokuda, Masaaki ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b Sankyo Labo Service Corporation   (Japan)

^c KAGAWA UNIVERSITY   (Japan)

^d MEIJO UNIVERSITY   (Japan)

Author keywords

Abdominal adiposity; D psicose; Glucokinase translocation; Glucose tolerance; Insulin resistance; Type 2 diabetes mellitus

Indexed keywords

DRINKING WATER; GLUCOKINASE; GLUCOSE; GLYCOGEN; INSULIN; PSICOSE;

ABDOMINAL FAT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; FATTY LIVER; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID STORAGE; LIVER; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; OTSUKA LONG EVANS TOKUSHIMA FATTY RAT; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; RAT;

ABDOMINAL FAT; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CELL NUCLEUS; CYTOPLASM; CYTOPROTECTION; DIABETES MELLITUS, TYPE 2; EATING; FATTY LIVER; FRUCTOSE; GLUCOKINASE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LIPID METABOLISM; MALE; PANCREAS; PROTEIN TRANSPORT; RATS; RATS, INBRED OLETF;

RATTUS;

EID: 79551479885     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.12.091     Document Type: Article

References (30)

1. Guo Z., Bu S., Yu Y., Ghatnekar G., Wang M., Chen L., Bu M., Yang L., Zhu B., Feng Z., Huang Q. Diazoxide prevents abdominal adiposity and fatty liver in obese OLETF rats at prediabetic stage. J. Diabetes Complications 2008, 22:46-55.
2. Twombly R. The big fat question: what is the role of excess weight in cancer risk, mortality? J. Natl. Cancer Inst. 2005, 97:1110-1112.
3. Aizawa T., Taguchi N., Sato Y., Nakabayashi T., Kobuchi H., Hidaka H., Nagasawa T., Ishihara F., Itoh N., Hashizume K. Prophylaxis of genetically determined diabetes by diazoxide: a study in a rat model of naturally occurring obese diabetes. J. Pharmacol. Exp. Ther. 1995, 275:194-199.
4. Mevorach M., Giacca A., Aharon Y., Hawkins M., Shamoon H., Rossetti L. Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus. J. Clin. Invest. 1998, 102:744-753.
5. Takeuchi H., Inoue Y., Ishihara H., Oka Y. Overexpression of either liver type or pancreatic beta cell type glucokinase via recombinant adenovirus enhances glucose oxidation in isolated rat hepatocytes. FEBS Lett. 1996, 393:60-64.
6. Nakagawa T., Goto H., Hussein G., Hikiami H., Shibahara N., Shimada Y. Keishibukuryogan ameliorates glucose intolerance and hyperlipidemia in Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Diabetes Res. Clin. Pract. 2008, 80:40-47.
7. Lim S., Yoon J.W., Choi S.H., Cho B.J., Kim J.T., Chang H.S., Park H.S., Park K.S., Lee H.K., Kim Y.B., Jang H.C. Effect of ginsam, a vinegar extract from Panax ginseng, on body weight and glucose homeostasis in an obese insulin-resistant rat model. Metabolism 2009, 58:8-15.
8. Toyoda Y., Ito Y., Tanigawa K., Miwa I. Impairment of glucokinase translocation in cultured hepatocytes from OLETF and GK rats, animal models of type 2 diabetes. Arch. Histol. Cytol. 2000, 63:243-248.
9. Agius L. New hepatic targets for glycaemic control in diabetes. Best Pract. Res. Clin. Endocrinol. Metab. 2007, 21:587-605.
10. Miwa I., Mitsuyama S., Toyoda Y., Nonogaki T., Aoki S., Okuda J. Evidence for the presence of rat liver glucokinase in the nucleus as well as in the cytoplasm. Biochem. Int. 1990, 22:759-767.
11. Cnop M., Welsh N., Jonas J.C., Jörns A., Lenzen S., Eizirik D.L. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 2005, 54(Suppl. 2):S97-S107.
12. Cree G.M., Perlin A.S. O-isopropylidene derivatives of d-allulose (d-psicose) and d-erythro-hexopyranos-2, 3-diulose. Can. J. Biochem. 1968, 46:765-770.
13. Takeshita K., Suga A., Takada G., Izumori K. Mass production of d-psicose from d-fructose by a continuous bioreactor system using immobilized d-tagatose 3-epimerase. J. Biosci. Bioeng. 2000, 90:453-455.
14. Granström T.B., Takata G., Tokuda M., Izumori K. Izumoring: a novel and complete strategy for bioproduction of rare sugars. J. Biosci. Bioeng. 2004, 97:89-94.
15. Matsuo T., Izumori K. d-psicose inhibits intestinal alpha-glucosidase and suppresses the glycemic response after ingestion of carbohydrates in rats. J. Clin. Biochem. Nutr. 2009, 45:202-206.
16. Matsuo T., Suzuki H., Hashiguchi M., Izumori K. d-psicose is a rare sugar that provides no energy to growing rats. J. Nutr. Sci. Vitaminol. (Tokyo) 2002, 48:77-80.
17. Iida T., Kishimoto Y., Yoshikawa Y., Hayashi N., Okuma K., Tohi M., Yagi K., Matsuo T., Izumori K. Acute d-psicose administration decreases the glycemic responses to an oral maltodextrin tolerance test in normal adults. J. Nutr. Sci. Vitaminol. (Tokyo) 2008, 54:511-514.
18. Hayashi N., Iida T., Yamada T., Okuma K., Takehara I., Yamamoto T., Yamada K., Tokuda M. Study on the postprandial blood glucose suppression effect of d-psicose in borderline diabetes and the safety of long-term ingestion by normal human subjects. Biosci. Biotechnol. Biochem. 2010, 74:510-519.
19. Moran T.H., Katz L.F., Plata-Salaman C.R., Schwartz G.J. Disordered food intake and obesity in rats lacking cholecystokinin A receptors. Am. J. Physiol. 1998, 274:R618-R625.
20. Gerich J.E. The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocr. Rev. 1998, 19:491-503.
21. Matsuo T. Inhibitory effects of d-psicose on glycemic responses after oral carbohydrate tolerance test in rats. J. Jpn. Soc. Nutr. Food Sci. 2006, 59:13-20.
22. Toeller M. Nutritional recommendations for diabetic patients and treatment with alpha-glucosidase inhibitors. Drugs 1992, 44(Suppl. 3):13-20.
23. Torres T.P., Catlin R.L., Chan R., Fujimoto Y., Sasaki N., Printz R.L., Newgard C.B., Shiota M. Restoration of hepatic glucokinase expression corrects hepatic glucose flux and normalizes plasma glucose in Zucker diabetic fatty rats. Diabetes 2009, 58:78-86.
24. Toyoda Y., Ito Y., Yoshie S., Miwa I. Shuttling of glucokinase between the nucleus and the cytoplasm in primary cultures of rat hepatocytes: possible involvement in the regulation of the glucose metabolism. Arch. Histol. Cytol. 1997, 60:307-316.
25. Agius L., Stubbs M. Investigation of the mechanism by which glucose analogues cause translocation of glucokinase in hepatocytes evidence for two glucose binding sites. Biochem. J. 2000, 346(Pt. 2):413-421.
26. Chu C.A., Fujimoto Y., Igawa K., Grimsby J., Grippo J.F., Magnuson M.A., Cherrington A.D., Shiota M. Rapid translocation of hepatic glucokinase in response to intraduodenal glucose infusion and changes in plasma glucose and insulin in conscious rats. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 286:G627-G634.
27. Abbott W.G., Lillioja S., Young A.A., Zawadzki J.K., Yki-Järvinen H., Christin L., Howard B.V. Relationships between plasma lipoprotein concentrations and insulin action in an obese hyperinsulinemic population. Diabetes 1987, 36:897-904.
28. Widén E., Ekstrand A., Saloranta C., Franssila-Kallunki A., Eriksson J., Schalin-Jäntti C., Groop L. Insulin resistance in type 2 (non-insulin-dependent) diabetic patients with hypertriglyceridaemia. Diabetologia 1992, 35:1140-1145.
29. Ko S.H., Kwon H.S., Kim S.R., Moon S.D., Ahn Y.B., Song K.H., Son H.S., Cha B.Y., Lee K.W., Son H.Y., Kang S.K., Park C.G., Lee I.K., Yoon K.H. Ramipril treatment suppresses islet fibrosis in Otsuka Long-Evans Tokushima fatty rats. Biochem. Biophys. Res. Commun. 2004, 316:114-122.
30. Finegood D.T., McArthur M.D., Kojwang D., Thomas M.J., Topp B.G., Leonard T., Buckingham R.E. Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death. Diabetes 2001, 50:1021-1029.